{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.86 vs. cons $3.80",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~5.2% vs. cons 5.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~29.0% vs. cons 28.9%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.0\u20136.0% vs. cons 5.4% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted operating-margin expansion guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~70\u201380 bps vs. cons 75 bps (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Free-cash-flow growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~10%+ vs. cons 12% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.4,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.6,
  "day5_path": "FADE",
  "day5_rationale": "A modest EPS and organic-growth beat should support the initial reaction, but unchanged FY2026 guidance implies limited out-period estimate upside; pred day-5 residual ~0.6% vs. day-1 residual 1.4%, producing a fade as the quarter's upside is partly offset by softer Reinsurance pricing and a high pre-report valuation bar.",
  "day5_confidence": "MEDIUM"
}